Cytokines and the regulation of apoptosis in reproductive tissues: A review

American Journal of Reproductive Immunology

Volumn 42, Issue 2, 1999, Pages 100-109

  Lea, Richard G ^a   Riley, Simon C ^b   Antipatis, Christos ^a   Hannah, Lisa ^a   Ashworth, Cheryl J ^a   Clark, David A ^c   Critchley, Hilary O D ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Apoptosis; Placenta; TNF

Indexed keywords

CYTOKINE; PROTEIN BAX; PROTEIN BCL 2; RETINOL; TUMOR NECROSIS FACTOR ALPHA;

ABORTION; APOPTOSIS; CONFERENCE PAPER; FETUS MEMBRANE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LABOR; MENSTRUATION; NEUTROPHIL; PLACENTA; PREGNANCY; PRIORITY JOURNAL; RETINOL DEFICIENCY; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

EID: 0032766948     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1999.tb00473.x     Document Type: Conference Paper

References (77)

1. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74:597-608.
2. Bargou RC, Bommert K, Weinmann P, Daniel PT, Wagener C, Mapara MY, Dorken B: Induction of Bax-alpha precedes apoptosis in a human B lymphoma cell line: Potential role of the bcl-2 gene family in surface IgM-mediated apoptosis. Eur J Immunol 1995; 25:770-775.
3. Oltavi ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 1994; 79:189-192.
4. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80:285-291.
5. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-1178.
6. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wans X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275:1129-1132.
7. Tabibzadeh S, Zupi E, Babaknia A, Liu R, Marconi D, Romanini C: Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Hum Reprod 1995; 10:277-286.
8. McLaren J, Prentice A, Charnock-Jones DS, Sharkey AM, Smith SK: Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 1997; 12:146-152.
9. Tao XJ, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, Tilly JL, Isaacson KB: Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium:glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin Endocrinol Metab 1997; 82:2738-2746.
10. Tao XJ, Sayegh RA, Tilly JL, Isaacson KB: Elevated expression of the proapoptotic BCL-2 family member, BAK, in the human endometrium coincident with apoptosis during the secretory phase of the cycle. Fertil Steril 1998; 70:338-343.
11. Kaipia A, Hsu SY, Hsueh AJ: Expression and function of a proapoptotic Bcl-2 family member Bcl-XL/Bcl-2-associated death promoter (BAD) in rat ovary. Endocrinology 1997; 138:5497-5504.
12. Yang X, Hao Y, Pater MM, Tang SC, Pater A: Enhanced expression of anti-apoptotic proteins in human papillomavirus-immortalized and cigarette smoke condensate-transformed human endocervical cells: Correlation with resistance to apoptosis induced by DNA damage. Mol Carcinog 1998; 22:95-101.
13. King A, Wellings V, Gardner L, Loke YW: Immunocytochemical characterisation of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989; 24:195-205.
14. Loke YW, King A: Uterine mucosal leukocytes. In Human Implantation. Cell Biology and Immunology, YW Loke, A King (eds). Cambridge, UK, Cambridge University Press, 1995, pp 102-129.
15. Koh EAT, Illingworth PJ, Duncan WC, Critchley HOD: Immunolocalization of bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Hum Reprod 1995; 10:1557-1562.
16. Lea RG, Al-Sharekh N, Tulppala M, Critchley HOD: The immunolocalisation of bcl-2 at the maternal-fetal interface in healthy and failing pregnancies. Human Reprod 1997a; 12:153-158.
17. Critchley HOD, Kelly RW, Lea RG, Drudy TA, Jones RL, Baird DT: Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod 1996; 11:2257-2262.
18. Critchley HOD, Drudy TA, Lea RG, Baird DT: Immunolocalisation of bcl-2 in human decidua following antigestogen administration. J Reprod Fert 1998; Abstr Ser 21; (Abstr 22):14.
19. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156:4027-4034.
20. Pecci A, Scholz A, Pelster D, Beato M: Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS. J Biol Chem 1997; 272:11791-11798.
21. Parr EL, Tung HN, Parr MB: Apoptosis as the mode of uterine cell death during embryo implantation in mice and rats. Biol Reprod 1987; 36:211-225.
22. Gu Y, Jow GM, Moulton BC, Lee C, Sensibar JA, Park-Sarge OK, Chen TJ, Gibori G: Apoptosis in decidual tissue regression and reorganization. Endocrinology 1994; 135:1272-1279.
23. Piacentini ML, Autori F: Immunohistochemical localisation of tissue transglutaminase and Bcl-2 in rat uterine tissues during embryo implantation and post-partum involution. Differentiation 1994; 57:51-61.
24. Akcali KC, Khan SA, Morton BC: Effect of decidualization on the expression of bax and bcl-2 in the rat uterine endometrium. Endocrinology 1996; 137:3123-3130.
25. Kokawa K, Shikone T, Nakano R: Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998a; 19:21-26.
26. Nelson DM: Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996; 17:387-391.
27. Smith SC, Baker PN, Symonds EM: Placental apoptosis in normal human pregnancy. Am J Obstet Gynaecol 1997; 177:57-65.
28. Lea RG, Riley SC, Tulppala M, Critchley HOD: Placental apoptosis and pregnancy failure. J Reprod Fert 1997b; Abstract Series 20 (Abstr 3): 4.
29. Kokawa K, Shikone T, Nakano R: Apoptosis in human chorionic villi and decidua in normal and ectopic pregnancy. Mol Human Reprod 1998b; 4:87-91.
30. Sakuragi N, Matsuo H, Coukos G, Furth EE, Bronner MP, VanArsdale CM, Krajewsky S, Reed JC, Strauss JF III: Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. J Soc Gynecol Investig 1994; 1:164-172.
31. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I, Berkowitz RS: c-myc, c-erbB-2, c-fms and bcl-2 onco-proteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 1998; 43:101-110.
32. Marana HR, Andrade JM, Martins GA, Silva JS, Sala MA, Cunha SP: A morphometric study of maternal smokine on apoptosis in the syncytiotrophoblast. Int J Gynaecol Obstet 1998; 61:21-27.
33. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-632.
34. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-1192.
35. Hunt JS, Vassmer D, Ferguson TA, Miller L: Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997; 158:4122-4128.
36. Bamberger A-M, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrin Metab 1997; 82:3173-3175.
37. Uckan D, Steele A, Cherry, Wang BY, Chamizo W, Koutsonikolis A, Gilbert-Barness E, Good RA: Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997; 3:655-662.
38. Zorzi W, Thellin O, Coumans B, Melot F, Hennen G, Lakaye B, Igout A, Heinen E: Demonstration of the expression of CD95 ligand transcript and protein in human placenta. Placenta 1998; 19:269-277.
39. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184:1075-1082.
40. Haidacher S, Blaschitz A, Desoye G, Dohr G: Immunohistochemical evidence of p53 protein in human placenta and choriocarcinoma cell lines. Hum Reprod 1995; 10:983-988.
41. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51:6304-6311.
42. Wegmann TG, Lin H, Guilbert L, Mossman TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
43. Guilbert LJ: There is a bias against type 1 (inflammatory) cytokine expression and function in pregnancy. Reprod Immunol 1996; 32:105-110.
44. Lea RG, Calder A: The immunology of pregnancy. Curr Op Infect Dis 1997; 10:171-176.
45. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG: Control of fetal survival in CBA × DBA, 2 mice by lymphokine therapy. J Reprod Fertil 1990; 89:447-458.
46. Tangri S, Raghupathy R: Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorption. Biol Reprod 1993; 49:850-856.
47. Silen ML, Firpo A, Morgello S, Lowry SF, Francus T: Interleukin-1 alpha and tumor necrosis factor alpha cause placental injury in the rat. Am J Pathol 1989; 135:239-244.
48. Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, Cerami A: Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989; 161:336-341.
49. Yui J, Garcia-Lloret M, Wegmann T, Guilbert L: Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15:819-835.
50. Coulam CB, Stephenson M, Stern JJ, Clark DA: Immunotherapy for recurrent pregnancy loss: Analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
51. Stern JJ, Dorfmann AD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB: Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65:250-253.
52. Lea RG, Tulppala M, Critchley HOD: Deficient syncytiotrophoblast TNF-α characterises failing first trimester pregnancies in a subgroup of recurrent miscarriage patients. Human Reprod 1997; 12:1313-1320.
53. Gendron RL, Nestel FP, Lapp WS, Baines MG: Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumour necrosis factor-alpha. J Reprod Fertil 1990; 90:395-402.
54. Lea RG, Mclntyre S, Baird J, Clark DA: Tumor necrosis factor-α mRNA positive cells in spontaneous resorption in rodents. Am J Reprod Immunol 1998; 39:50-57.
55. Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth retardation. Am J Obstet Gynaecol 1997; 177:1395-1401.
56. Rivera DL, Olister SM, Liu X, Thompson JH, Zhang XJ, Pennline K, Azuero R, Clark DA, Miller MJS: Interleukin 10 attenuates experimental fetal growth retardation and demise. FASEB J 1998; 12:189-197.
57. Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ: Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol 1996; 167:324-332.
58. Xiao J, Garcia Lloret M, Winkler-Lowen B, Miller R, Simpson K, Guilbert L: ICAM-1-mediated adhesion of peripheral blood monocytes to the surface of placental syncytiotrophoblasts. Am J Pathol 1997; 150:1845-1860.
59. Walter PR, Garin Y, Blot P: Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol 1982; 109:330-342.
60. Fried M, Muga RO, Misore AO, Duffy PE: Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J Immunol 1998; 160:2523-2530.
61. Artal R, Sokol RJ, Neuman M, Burstein AH, Stojkov J: The mechanical properties of prematurely and non-prematurely ruptured membranes. Methods and preliminary results. Am J Obstet Gynecol 1976; 125:655-659.
62. Runic R, Lockwood CJ, LaChapelle L, Dipasquale B, Demopoulis RI, Kumar A, Guller S: Apoptosis and Fas ligand in human fetal membranes. J Clin Endocrin Metabol 1998; 83:660-666.
63. Riley SC, Anderson JD, Calder AA, Howe DC: Apoptosis occurs in trophoblast of chorion laeve during labour. J Obstet Gynaecol 1998; 18: (Abstr) S18-S19.
64. Riley SC, Wisely KA, Calder AA, Howe DC: Apoptosis in chorion trophoblast cells of the fetal membranes at the end of pregnancy: its putative role in the initiation of labour and regulation by bcl-2 and bax. J Reprod Fert 1997; Abstr Ser 20:(Abstr 4) 5.
65. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S: Expression of Fas ligand by human cytotrophoblasts: Implications in placentation and fetal survival. J Clin Endocrinol Metab 1996; 81:3119-3122.
66. Mitchell MD, Trautman MS, Dudley DJ: Cytokine networking in the placenta. Placenta 1993; 14:249-275.
67. Casey ML, Cox SM, Beutler B, Milewich L, MacDonald PC: Cachectin tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J Clin Invest 1989; 83:430-436.
68. Kelly RW: Pregnancy maintenance and parturition: The role of prostaglandin in manipulating the immune and inflammatory response. Endocr Rev 1994; 15:684-706.
69. Kaga N, Katsuki Y, Futamura Y, Obata M, Shibutani Y: Role of urinary trypsin inhibitor in the maintenance of pregnancy in mice. Obstet Gynecol 1996; 88:872-882.
70. Kakinuma C, Kuwayama C, Nobuhiko K, Futamura Y, Katsuki Y, Shibutani Y: Trophoblastic apoptosis in mice with preterm delivery and its suppression by urinary trypsin inhibitor. Obstet Gynaecol 1997; 90:117-124.
71. Wiedermann U, Chen XJ, Enerback L, Hanson LA, Kahu H, Dahlgren UI: Vitamin A deficiency increases inflammatory responses. Scand J Immunol 1996; 44:578-584.
72. Hanson LA, Hahn-Zoric M, Wiedermann U, Lundin S, Dahlman-Hoglund A, Saalman R, Erling E, Dahlgren U, Telemo E: Early dietary influence on later immunocompetence. Nutr Rev 1996; 54:S23-S50.
73. Katz J, Khatry SK, West KP, Humphrey JH, Leclerq SC, Pradhan EK, Pohkrel RP, Sommer A: Night blindness is prevalent during pregnancy and lactation in rural Nepal. J Nutrn 1995; 2122-2127.
74. Underwood BA: Maternal vitamin A status and its importance in infancy and childhood. Am J Clin Nutrn 1994; 59:5175-5245.
75. Antipatis C, Ashworth CJ, Grant G: Vitamin A deficiency and supplementation during pregnancy affects fetal and placental growth, J Reprod Fert 1998a; Abstr Ser 21 (Abstr 89):37
76. Antipatis C, Ashworth CJ, Grant G, Lea RG, Hay S, Rees WD: The effects of maternal vitamin A status on fetal heart and lung; changes in the expression of key developmental genes. Am J Physiol 1998b; 275:L1184-L1191.
77. Antipatis C, McArdle HJ, Ashworth CJ, Brown D, Riley SC, Lea RG: Effects of maternal vitamin A deficiency on placental morphology and function. J Reprod Fert 1997, Abstr Ser 20 (Abstr 1):4.